Hypertension-associated thrombotic microangiopathy in an adult patient with complement factor H autoantibodies and a rare heterozygous variant in the CFH gene

被引:3
作者
Roldao, Marisa [1 ]
Alves, Rita Valerio [1 ]
Escoli, Rachele [1 ]
Goncalves, Hernani [1 ]
Lopes, Karina [1 ]
机构
[1] Ctr Hosp Medio Tejo, Dept Nephrol, P-2350754 Torres Novas, Portugal
关键词
atypical hemolytic uremic syndrome; thrombotic microangiopathy; alternative complement pathway; CFH autoantibodies; CFH gene; hypertension; shear stress; case report; HEMOLYTIC-UREMIC SYNDROME; INHIBITOR ECULIZUMAB; C3;
D O I
10.5414/CN110416
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal injury, which results from thrombotic microangiopathy (TMA) within the glomerular capillaries and arterioles. We report a case of a biopsy-proven renal TMA attributed to hypertension in a 42-year-old woman with undiagnosed alternative complement pathway dysregulation resulting from a rare association between complement factor H (CFH) autoantibodies and a heterozygous variant in the CFH gene. We propose that severe hypertension triggered an over-activation of the alternative complement pathway in a patient with genetic predisposition. In this case, blood pressure control allowed normalization of hematologic parameters and partial recovery of renal function, supporting the idea that shear stress is an important complement-amplifying factor.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 18 条
[1]   Thrombotic Microangiopathy and the Kidney [J].
Brocklebank, Vicky ;
Wood, Katrina M. ;
Kavanagh, David .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (02) :300-317
[2]   Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome [J].
Cavero, Teresa ;
Arjona, Emilia ;
Soto, Karina ;
Caravaca-Fontan, Fernando ;
Rabasco, Cristina ;
Bravo, Luis ;
de la Cerda, Francisco ;
Martin, Nadia ;
Blasco, Miquel ;
Avila, Ana ;
Huerta, Ana ;
Cabello, Virginia ;
Jarque, Ana ;
Alcazar, Concepcion ;
Fulladosa, Xavier ;
Carbayo, Javier ;
Anaya, Sara ;
Cobelo, Carmen ;
Ramos, Natalia ;
Iglesias, Elena ;
Baltar, Jose ;
Martinez-Gallardo, Rocio ;
Perez, Lourdes ;
Morales, Enrique ;
Gonzalez, Roberto ;
Macia, Manuel ;
Draibe, Juliana ;
Pallardo, Luis ;
Quintana, Luis F. ;
Espinosa, Mario ;
Barros, Xoana ;
Pereira, Fernando ;
Cao, Mercedes ;
Antonio Moreno, Juan ;
Rodriguez de Cordoba, Santiago ;
Praga, Manuel .
KIDNEY INTERNATIONAL, 2019, 96 (04) :995-1004
[3]   Anti-complement-factor H-associated glomerulopathies [J].
Dragon Durey, Marie-Agnes ;
Sinha, Aditi ;
Togarsimalemath, Shambhuprasad Kotresh ;
Bagga, Arvind .
NATURE REVIEWS NEPHROLOGY, 2016, 12 (09) :563-578
[4]   Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome [J].
Dragon-Durey, Marie-Agnes ;
Sethi, Sidharth Kumar ;
Bagga, Arvind ;
Blanc, Caroline ;
Blouin, Jacques ;
Ranchin, Bruno ;
Andre, Jean-Luc ;
Takagi, Nobuaki ;
Cheong, Hae Il ;
Hari, Pankaj ;
Le Quintrec, Moglie ;
Niaudet, Patrick ;
Loirat, Chantal ;
Fridman, Wolf Herman ;
Fremeaux-Bacchi, Veronique .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (12) :2180-2187
[5]  
El Karoui K, 2019, KIDNEY INT, V96, P1239, DOI 10.1016/j.kint.2019.07.023
[6]   Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial [J].
Fakhouri, Fadi ;
Hourmant, Maryvonne ;
Campistol, Josep M. ;
Cataland, Spero R. ;
Espinosa, Mario ;
Gaber, A. Osama ;
Menne, Jan ;
Minetti, Enrico E. ;
Provot, Francois ;
Rondeau, Eric ;
Ruggenenti, Piero ;
Weekers, Laurent E. ;
Ogawa, Masayo ;
Bedrosian, Camille L. ;
Legendre, Christophe M. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (01) :84-93
[7]   Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults [J].
Fremeaux-Bacchi, Veronique ;
Fakhouri, Fadi ;
Gamier, Arnaud ;
Bienaime, Frank ;
Dragon-Durey, Marie-Agnes ;
Ngo, Stephanie ;
Moulin, Bruno ;
Servais, Aude ;
Provot, Francois ;
Rostaing, Lionel ;
Burtey, Stephane ;
Niaudet, Patrick ;
Deschenes, Georges ;
Lebranchu, Yvon ;
Zuber, Julien ;
Loirat, Chantal .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (04) :554-562
[8]   Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference [J].
Goodship, Timothy H. J. ;
Cook, H. Terence ;
Fakhouri, Fadi ;
Fervenza, Fernando C. ;
Fremeaux-Bacchi, Veronique ;
Kavanagh, David ;
Nester, Carla M. ;
Noris, Marina ;
Pickering, Matthew C. ;
de Cordoba, Santiago Rodriguez ;
Roumenina, Lubka T. ;
Sethi, Sanjeev ;
Smith, Richard J. H. .
KIDNEY INTERNATIONAL, 2017, 91 (03) :539-551
[9]   Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome [J].
Greenbaum, Larry A. ;
Fila, Marc ;
Ardissino, Gianluigi ;
Al-Akash, Samhar I. ;
Evans, Jonathan ;
Henning, Paul ;
Lieberman, Kenneth V. ;
Maringhini, Silvio ;
Pape, Lars ;
Rees, Lesley ;
van de Kar, Nicole C. A. J. ;
Vande Walle, Johan ;
Ogawa, Masayo ;
Bedrosian, Camille L. ;
Licht, Christoph .
KIDNEY INTERNATIONAL, 2016, 89 (03) :701-711
[10]   Atypical Hemolytic Uremic Syndrome [J].
Kavanagh, David ;
Goodship, Tim H. ;
Richards, Anna .
SEMINARS IN NEPHROLOGY, 2013, 33 (06) :508-530